Amyris, Inc. (AMRS) Gains As Market Dips: What You Should Know

This story originally appeared on Zacks

Amyris, Inc. closed. (AMRS) at $4.59 in the latest trading session, recording a move of 1.1% from the previous day. The stock surpassed the S&P 500’s daily loss of 0.41%. Meanwhile, the Dow Jones Index lost 0.01%, and the tech-heavy Nasdaq gained 0.13%.

– Zacks

Prior to today’s trading, the company’s shares have lost 26.3% over the past month. This slowed the basic materials sector’s gains by 4.05% and the S&P 500’s gains by 2.36% in that time.

Investors hope to gain strength from Amyris, Inc. As it nears its next earnings release. On that day, Amyris, Inc. is expected to announce. Earnings of – $0.20 per share, which represents a year-over-year growth of 54.55%. Meanwhile, our latest consensus estimate calls for revenue of $64.1 million, down 19.61% from the prior year quarter.

Also note should be any recent changes to analyst estimates for Amyris, Inc. by investors. These recent reviews tend to reflect the evolving nature of short-term business trends. With this in mind, we can take the positive rating reviews as a sign of optimism about the company’s business outlook.

Research indicates that these discretionary revisions are directly related to the stock’s near-term price momentum. To take advantage of this, we have developed Zacks Rank, a proprietary model that takes these discretionary changes into account and provides an actionable ranking system.

Ranging from #1 (strong buy) to #5 (strong sell), the Zacks Rank system has an externally audited track record of outperforming, returning the #1 stock an average of +25% per year since 1988. Zacks consensus has been profitability estimates The stock is stagnant over the past month. Amyris, Inc. Currently rated Zacks No. 3 (Hold).

The specialty chemicals industry is part of the basic materials sector. This group has a Zacks Industry Rating of 163, placing it in the bottom 37% of all 250+ industries.

Zacks Industry Ranks are listed in order from best to worst in terms of the average Zacks rating of individual companies in each of these sectors. Our research shows that industries ranked 50% outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on

Zacks Names “Single Best Pick to Double”

Out of thousands of stocks, 5 experts from Zacks each chose their favorite to skyrocket +100% or more in the coming months. Of these five, Research Director Shiraz Mian chooses someone with the most explosive positive side of all.

In the words of one investor, “Cure and prevent hundreds of diseases… what should this market be worth?” This company can rival or outperform other recent Zacks stocks that are set to double like Boston Beer which is up +143.0% in just over 9 months and NVIDIA which is booming +175.9% in one year.

FREE: See our top stocks and 4 runner-ups >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 of the best stocks for the next 30 days. Click for this free report

Amyris, Inc. (AMRS): Free Stock Analysis Report

To read this article on click here.


Leave a Comment